CITIC Capital to acquire New Zealand's Trilogy for $175m
CITIC Capital has agreed to buy Trilogy International (TIL), a producer of skincare products and fragrances listed in New Zealand and Australia, for NZ$250 million ($175 million) via a scheme of arrangement.
The China-focused GP will buy all outstanding shares in the company for NZ$2.90 apiece, a 27.8% premium to the December 14 closing price. The enterprise valuation equates to 13.6x EBITDA for the 12 months...
More on Australasia
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.